Delivery Order SPE2DB20D2014-SPE2DB25FA67Y

Award Date 12/31/24
Potential Completion Date 1/2/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.50 firm fixed-price contract is for the delivery of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a medical product used in healthcare settings. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This delivery order is part of a larger Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract has a ceiling value of $3,498.20 and an ultimate completion date of September 4, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product. The contract has a completion date of February 27, 2024 and a potential value of $1,372.94. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, as the prime contractor, holds an Indefinite Delivery Contract (IDC) with DLA with a...
This federal contract award is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,368.80 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 16, 2024, with an ultimate completion date of December 17, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a $1,399.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML pharmaceuticals. The award has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the...
This federal contract award, valued at $1,507.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML intravenous infusion bottles, with a completion date of December 8, 2023. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 100ML to the Defense Logistics Agency (DLA). The award, valued at $2,645.60, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,137.60, is for the delivery of OMNIPAQUE 300 MG/ML Infusion Bottles (100ML) to support federal healthcare programs. The contract has a firm fixed price pricing type and a completion date of February 17, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $3,619.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medical product "OMNIPAQUE 350 MG/ML PLUSPAK 500ML" and has a firm fixed price. It was awarded on December 18, 2024, with a completion date of December 19, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,119.42 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a completion date of December 20, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA67Y
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a medical product. The award has a ceiling value of $1,399.77 and a completion date of January 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/1/25, 10:51 AM